Want to see KR:000640 full AI Analyst Report?
Top Page
Dong-A Socio Holdings Co., Ltd.
(000640)
Select Model
Select Model
Rating:61Neutral
Price Target:
₩93,368.00
Action:N/A
Date:10/28/26
The score is driven primarily by moderate underlying financial performance (steady revenue growth, improving leverage, and currently solid free cash flow, but with uneven margins and cash-flow volatility). This is partially offset by weak technical momentum (below key moving averages with a negative MACD). Valuation is a clear positive, with a low P/E and a modest dividend yield supporting the overall rating.
Positive Factors
Revenue Growth and Profitability
The group combines continued revenue expansion with solid gross and EBITDA margins, indicating a functioning portfolio of healthcare businesses with underlying operating scale. This earnings base can support reinvestment and strategic development, although conversion to net income remains less consistent.
Negative Factors
Choppy Net Margins
Moderate and uneven net margins indicate that revenue growth does not consistently translate into bottom-line earnings. This can limit internal funding capacity and make results more sensitive to operating costs, subsidiary performance, and the mix of healthcare businesses within the portfolio.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth and Profitability
The group combines continued revenue expansion with solid gross and EBITDA margins, indicating a functioning portfolio of healthcare businesses with underlying operating scale. This earnings base can support reinvestment and strategic development, although conversion to net income remains less consistent.
Read all positive factors
Dong-A Socio Holdings Co., Ltd. (000640) vs. SPDR S&P 500 ETF (SPY)
Market Cap
₩581.17B
Dividend Yield1.94%
Average Volume (3M)9.04K
Price to Earnings (P/E)6.9
Beta (1Y)0.13
Revenue Growth10.06%
EPS Growth-3.74%
CountryKR
Employees82
SectorGeneral
Sector StrengthN/A
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)12512.15
Shares Outstanding6,732,527
10 Day Avg. Volume11,612
30 Day Avg. Volume9,043
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)0.63
Price to Sales (P/S)0.50
P/FCF Ratio4.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11,146.33
Revenue Forecast (FY)₩1.59T
Dong-A Socio Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Dong-A Socio Holdings Co., Ltd., established in Seoul, South Korea in 1932, maintains a prominent role in the pharmaceutical industry both within South Korea and globally. Its diverse product range includes well-known items such as Bacchus, Benach...
Dong-A Socio Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
68
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.52T | 1.43T | 1.33T | 1.13T | 1.01T | 881.94B |
| Gross Profit | 473.88B | 439.47B | 408.07B | 374.87B | 294.39B | 281.48B |
| EBITDA | 199.71B | 193.15B | 194.87B | 141.37B | 88.10B | 136.98B |
| Net Income | 85.25B | 90.94B | 58.02B | 57.99B | 11.15B | 60.27B |
Balance Sheet | ||||||
| Total Assets | 2.21T | 2.08T | 2.03T | 1.96T | 1.73T | 1.69T |
| Cash, Cash Equivalents and Short-Term Investments | 214.40B | 145.78B | 127.34B | 160.49B | 105.76B | 158.47B |
| Total Debt | 687.36B | 662.55B | 739.97B | 691.88B | 552.13B | 537.58B |
| Total Liabilities | 1.00T | 927.77B | 966.55B | 929.80B | 732.79B | 706.35B |
| Stockholders Equity | 1.19T | 1.14T | 1.05T | 1.01T | 981.99B | 965.16B |
Cash Flow | ||||||
| Free Cash Flow | 176.68B | 154.14B | 7.43B | -825.27M | -2.73B | 52.36B |
| Operating Cash Flow | 233.34B | 203.41B | 82.99B | 158.70B | 75.87B | 131.09B |
| Investing Cash Flow | -65.25B | -72.23B | -45.18B | -161.36B | -42.47B | -136.61B |
| Financing Cash Flow | -90.74B | -125.62B | -40.45B | 27.39B | -38.00B | 16.03B |
Dong-A Socio Holdings Co., Ltd. Technical Analysis
Negative
―
Price Trends
92386.00
Negative
87712.25
Negative
93407.65
Negative
Market Momentum
-1002.19
Positive
37.76
Neutral
13.75
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:000640, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 92120.00, equal to the 50-day MA of 92386.00, and equal to the 200-day MA of 93407.65, indicating a bearish trend. The MACD of -1002.19 indicates Positive momentum. The RSI at 37.76 is Neutral, neither overbought nor oversold. The STOCH value of 13.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:000640.
Dong-A Socio Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₩560.29B | 5.53 | ― | 2.80% | 10.50% | 96.29% | |
61 Neutral | ₩581.17B | 6.94 | ― | 1.94% | 10.06% | -3.74% | |
61 Neutral | ₩1.15T | 5.90 | ― | 0.60% | 9.87% | 160.28% | |
60 Neutral | ₩404.42B | 8.96 | ― | 1.56% | -0.65% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ₩435.39B | -884.82 | ― | 0.08% | 6.21% | 95.65% | |
50 Neutral | ₩369.99B | 64.89 | ― | 3.33% | 22.17% | -38.54% |
* General Sector Average
KR:000640
Dong-A Socio Holdings Co., Ltd.
87,600.00
-18,769.28
-17.65%
KR:001060
JW Pharmaceutical Corporation
23,200.00
191.16
0.83%
KR:003000
Bukwang Pharmaceutical Co., Ltd.
3,750.00
95.20
2.60%
KR:019170
Shinpoong Pharmaceutical Co., Ltd.
8,460.00
-5,550.00
-39.61%
KR:069620
Daewoong Pharmaceutical Co., Ltd.
99,900.00
-39,418.48
-28.29%
KR:249420
Ildong Pharmaceutical Co., Ltd.
12,790.00
-10,206.94
-44.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.